WuXi Biologics (Cayman), Inc. (WXIBF)
4.30
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
WuXi Biologics Market Cap : 17.77B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| WuXi AppTec Co., Ltd. | 49.87B |
| Viva Biotech Holdings | 427.92M |
| Genscript Biotech Corp. | 3.769B |
| Pharmaron Beijing Co., Ltd. | 3.546B |
| Austar Lifesciences Ltd. | 35.88M |
Market Cap Related Metrics
| PE Ratio | 26.63 |
| PS Ratio | 5.920 |
| PEG Ratio | 0.5639 |
| Price to Free Cash Flow | 45.33 |
| Price | 4.30 |
| Earnings Yield | 3.76% |
| PEGY Ratio | 0.5639 |
| Operating PE Ratio | 19.39 |
| Normalized PE Ratio | 31.27 |